Overview

Gender

male

Investor Type

Investment Partner

Doug joined Delphi Ventures as an Associate in 1998 and became a Partner in 2000. His primary investment focus at Delphi is on medical devices and diagnostics.

Prior to joining Delphi, Doug was an Associate with Alex. Brown's Healthcare Investment Banking Group in San Francisco. While at Alex. Brown, Doug assisted in the execution of over a dozen financing and merger transactions involving both Fortune 500 and venture-backed medical technology companies, including a number of Delphi portfolio companies.

Previously, Doug was with Putnam Associates, a consulting firm focused on the biopharmaceutical industry, where his primary role was to develop and implement a strategy for the launch of a leading biotech drug. Doug’s board involvement includes the following: Anulex Technologies, Inc., Evalve, Inc., Labcyte, Inc., Soteira, Inc., TranS1, Inc. (TSON), TriVascular, Inc., and Vibrynt, Inc.

Doug holds an AB from Dartmouth College.